Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies regarding their COVID-19 vaccines.
Moderna stock...
CHARM Therapeutics (“CHARM”, “The Company”), announces today a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with General Catalyst, Khosla Ventures, Braavos...
Biotechnology company Bavarian Nordic (BAVA.CO) expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its...
Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and oversubscribed Series A financing...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the U.S. Food and Drug Administration...
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from...